Wendy E Hoy

Nov 5, 2024 | digitalcommons.library.tmc.edu | Vishal Diwan |Wendy E Hoy |Zaimin Wang |Jianzhen Zhang

RATIONALE & OBJECTIVE: Little is known about hospital admissions in nondialysis patients with chronic kidney disease (CKD) before death or starting kidney replacement therapy (KRT). STUDY DESIGN: Retrospective observational cohort study.

Nov 5, 2024 | digitalcommons.library.tmc.edu | Wendy E Hoy |Zaimin Wang |Jianzhen Zhang |Vishal Diwan

AIM: To describe adults with (non-dialysis) chronic kidney disease (CKD) in nine public renal practice sites in the Australian state of Queensland. METHODS: 7,060 persons were recruited to a CKD Registry in May 2011 and until start of kidney replacement therapy (KRT), death without KRT or June 2018, for a median period of 3.4 years.

Feb 12, 2024 | genomemedicine.biomedcentral.com | Rodney Lea |Wendy E Hoy |Simon Lee |Susan Mott |Judith Savige |John Mathews | +3 more

We used the key markers of kidney function eGFR and ACR to stratify CKD prognosis and assess the risk of kidney disease. Based on the eGFR (< 60 ml/min/1.73 m2) threshold for chronic kidney disease, our findings indicate that 5.7% (95% CI [3.8%, 8.1%], p < 0.001) of the study population exhibited signs of renal disease. In contrast, individuals in the Tiwi cohort with an ACR > 30 mg/mmol account for 20.3% of the population and are at high risk of CKD (Additional file 1: Table S2).

Nov 22, 2023 | spectator.com.au | Wendy E Hoy |Augusto Zimmermann

Since the introduction of Covid vaccines, the official narrative in Australia (and other parts of the world) is that these vaccines are safe, efficacious, and working well. However, this claim is considered to be untrue, as demonstrated by both the science and the statistics.

Oct 11, 2023 | onlinelibrary.wiley.com | Nobuo Tsuboi |John Bertram |Wendy E Hoy

Letter to the Editor Regarding: Clinical findings and kidney morphology in chronic kidney disease of unknown cause in India Nobuo Tsuboi,  Corresponding Author Nobuo Tsuboi Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan Correspondence: Nobuo Tsuboi, Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo, Japan.